The Science of Psilocybin.
And Beyond.
Deep psilocybin neuroscience — receptor binding, neuroplasticity, clinical protocols, veteran restoration — plus research on other psychedelic compounds. Published daily. Every claim backed by peer-reviewed data.
Featured Articles
The Fast Lane
Almost every quick thought you have rides on one tiny gate: the AMPA receptor, the workhorse that carries nearly all the brain’s fast excitatory traffic. Move a few more of these gates into a synapse and the connection grows stronger — the molecular basis of learning (Malinow & Malenka 2002). It’s also the final common path for fast-acting antidepressants: ketamine’s mood effect depends on AMPA (Maeng et al. 2008)…
The Little Brain
Tucked under the back of your skull sits a fist-sized lump we long dismissed as a simple movement machine. It’s the cerebellum — the little brain — and it holds about four out of every five neurons in your head (Herculano-Houzel 2009). Damage it and thinking and emotion itself can unravel (Schmahmann & Sherman 1998). It even lights up under psychedelics…
The Switch That Keeps You Awake
Deep in the base of your brain, a few thousand cells make a chemical that decides, moment to moment, whether you are awake or asleep. It is called orexin (also hypocretin), discovered by two teams at once in 1998. When these cells are lost, people develop narcolepsy (Thannickal et al. 2000) — and blocking orexin on purpose is how a new class of sleeping pills works…
The Other Half of the Brain
For a century we told the story of the brain as a story about neurons. But about half the cells in your head are not neurons at all — they are glia, and the most common are star-shaped astrocytes. Far from being passive glue, they wrap around every synapse, listen to the conversation, and answer back (Araque et al. 1999)…
The Guardian Within
Most receptors sit on the cell’s surface, waiting for a signal. The sigma-1 receptor hides deep inside the cell, at the junction of the endoplasmic reticulum and mitochondria, working as a chaperone that helps cells survive stress (Hayashi & Su 2007). In 2009 it became one of the strangest findings in psychedelic science: the brain’s own DMT is a natural key to it (Fontanilla et al. 2009). The spirit molecule may have a quiet second job — not visions, but protecting the cell from within…
The Old Medicine
Long before LSD or psilocybin, people ate a small spineless cactus in the northern deserts and boiled a tall green one high in the Andes. The molecule in both is mescaline — the first psychedelic ever isolated and, by the archaeological record, the oldest humans have used, reaching back roughly 5,700 years (El-Seedi et al. 2005). A phenethylamine, not a tryptamine, yet it works through the same 5-HT2A receptor — just far more slowly, over a 6-to-14-hour arc (Ley et al. 2024)…
The Seat of the Soul
Descartes called the pineal gland the seat of the soul; the ‘spirit molecule’ hypothesis made it the source of DMT released at birth, in dreams, and at death. This deep dive separates romance from evidence. DMT is genuinely endogenous — found in rat pineal microdialysate (Barker et al. 2013) and synthesized by the brain at serotonin-like levels (Dean et al. 2019). But there’s no evidence the tiny pineal makes psychoactive amounts (Nichols 2018). A real molecule, a beautiful myth, an honest middle…
The Blue Spot
Deep in the brainstem sits a speck of blue no bigger than a grain of rice — the locus coeruleus, the brain’s only source of noradrenaline and the master dial of arousal, attention, and the balance between focus and exploration (Aston-Jones & Cohen 2005). Classic psychedelics reach into it: they quiet its background firing while amplifying its response to the outside world through 5-HT2 receptors (Rasmussen & Aghajanian 1986) — a possible clue to why everything can feel newly vivid and meaningful…
The Waking Dream
The oldest word for a trip is ‘dreamlike’ — and the neuroscience runs deeper than metaphor. Serotonin normally promotes waking and suppresses REM sleep (Monti 2011); a 5-HT2A agonist reduces both REM and slow-wave sleep in animals (Monti & Jantos 2006). Yet in humans, daytime ayahuasca reduced REM and boosted deep slow-wave sleep without disrupting the night (Barbanoj et al. 2008), and psilocybin delayed REM onset much like a classical antidepressant (Dudysová et al. 2020)…
The Other Door
Almost every classic psychedelic works through one receptor — serotonin 5-HT2A. Salvia divinorum is the great exception. Its molecule, salvinorin A, is a potent and selective agonist of the kappa opioid receptor (Roth et al. 2002) — a completely different doorway to altered consciousness. In humans, the opioid blocker naltrexone abolishes its effects while the serotonin blocker ketanserin does not (Maqueda et al. 2016), proving the mechanism…
The Chemistry of Connection
MDMA’s signature is closeness — and a large part of it is one ancient molecule. MDMA triggers a robust release of oxytocin, and in humans the rise in oxytocin tracks the rise in prosocial feeling more closely than blood MDMA itself (Dumont et al. 2009). In animals, blocking oxytocin blunts MDMA’s sociability, and the release runs through 5-HT1A receptors on oxytocin neurons (Thompson et al. 2007). A single dose can even reopen a critical period for social reward learning (Nardou et al. 2019)…
The Inflamed Mind
Depression may be, in part, an inflamed brain — and psychedelics are turning out to be startlingly potent anti-inflammatories. Activating the 5-HT2A receptor blocks TNF-α-driven inflammation at picomolar doses (Yu et al. 2008), an effect that holds in living animals (Nau et al. 2013). Psilocin quiets the brain’s own immune cells, the microglia, dialing down their reactive oxygen species and phagocytosis in a 5-HT2-dependent way (Kozłowska et al. 2024)…
Precision-dosed psilocybin
mushroom products.
Engineered for daily ritual, neural reconstruction, and sustained cognitive performance. Lab-tested. Ceremony-ready.
Shop OOTW · 10% Off With Code JOURNAL10About Out Of This World
We operate at the threshold where ancient plant wisdom meets modern clinical observation. OOTW JOURNAL exists because psilocybin science deserves a dedicated platform — one that treats the research with the seriousness it demands. No hype. No speculation. Only mechanisms, clinical data, and protocols.
Our primary focus is psilocybin: receptor pharmacology, neuroplasticity, BDNF expression, veteran restoration, daily microdosing protocols. We also cover adjacent psychedelic compounds and consciousness research. New articles published daily. Every claim backed by peer-reviewed data.
Shop OOTW · 10% Off With Code JOURNAL10 open_in_new